Abstract Our search for potential anti-acetylcholinesterase (AChE) inhibitors for treatment of Alzheimer's disease has led to the discovery of two bioactive compounds, a-mangostin (11) and congestiflorone acetate (13). This discovery was achieved from a preliminary screening of the antiAChE activity on the extracts of three Mesua species namely M. ferrea, M. beccariana and M. congestiflora using Ellman's method. The pure metabolites, 1-12 which were isolated from the Mesua species, along with a synthetic derivative, compound 13 were then evaluated for their activities in order to identify the compounds that correspond to the enzyme inhibitory activities. Compounds 11 and 13 were found to give significant anti-AChE activities with IC 50 values of 17.51 and 20.25 lM.
Introduction
Deterioration disorders of nerves in human beings can lead to many neurodegenerative diseases such as Alzheimer's diseases, myasthenia gravis and glaucoma. These diseases occur commonly among the elderly citizens (Association, 2013) . However, it is also found to attack younger generation as well especially those with existing sicknesses such as diabetes and cardiovascular diseases. Recent reports have shown that pesticides could affect the nervous system by disrupting the enzyme that regulates acetylcholine, a neurotransmitter (Dési and Nagymajtényi, 1988) . Tacrine is a well-known acetyl-cholinesterase enzyme (AChE) inhibitor. However, it gives severe side effects to the patients such as nausea, insomnia and salivation (Yoshida and Suzuki, 1993) . Therefore, new approaches for these disorders need to be conducted as these diseases are inevitable to us. Mesua was chosen for the pharmacognosy investigation as it is traditionally used in folk medicines. Mesua spp. are traditionally used for the treatment of fever, dyspepsia, renal diseases, asthma, cough and nausea (Dennis et al., 1988) . Previous studies on Mesua species have shown these plants to possess lead compounds which can be developed into pharmaceutical products. The biological activities include cytotoxicity (Mahavorasirikul et al., 2010; Teh et al,. 2012 Teh et al,. , 2013 Teh et al,. ), antioxidant (D et al., 2012 Rajesh et al., 2013) , larvicidal (Singha et al., 2011) , hepatoprotective (Garg et al., 2009) , antiarthritic (Jalalpure et al., 2011) , immunomodulatory (Chahar et al., 2012) , antibacterial (Verotta et al., 2004) and anti-acetylcholinesterase (AChE) (Awang et al., 2010) activities. Previous studies on some Mesua sp. have revealed these biological activities to be contributed by secondary metabolites such as xanthones (Bandaranayake et al., 1975; Walia and Mukerjee, 1984) , coumarins (Awang et al., 2010; Bala and Seshadri, 1971) , biflavonoids and triterpenoids (Raju et al., 1976) . Based on this information, we decide to select Mesua plants for detailed phytochemical and pharmacological investigations. The objective of this study is to discover phytochemical constituents which can be developed into drugs through preclinical and clinical developments from extracts of three Mesua plants which possess promising anti-cholinesterase activities. The species selected were M. ferrea, M. beccariana and M. congestiflora. Compounds 1-12 (Teh et al., 2013) were successfully isolated from these Mesua species along with a derivative compound, congestiflorone acetate (13) (see Fig. 1 ). The anti-cholinesterase assay results of these compounds, together with the structure-activity relationship predictions, are reported in this paper.
Experimental section Chemicals
Acetylcholinesterase enzyme from electrophorus electricus (electric eel) Type VI-S 1KU (AChE; code: C3389), acetylthiocholine iodide (ATCI; code: A5751), 5,5 0 -dithiobis(2-nitrobenzoic) acid (DTNB; code: D8130), sodium phosphate monobasic (NaH 2 PO 4 ; code: S0751) and sodium phosphate dibasic (Na 2 HPO 4 ; code: S0876) and tacrine hydrochloride (A79922) were purchased from Sigma Aldrich, Malaysia. All solvents and silica gels were purchased from Merck, Darmstadt, Germany.
Plant material
The air-dried and powdered materials of M. beccariana stem bark (3 kg) were macerated and extracted consecutively with n-hexane, dichloromethane, ethyl acetate and methanol. The macerates were evaporated to dryness to yield the hexane (15.6 g), dichloromethane (21.2 g), ethyl acetate (15.8 g) and methanol (80.5 g) extracts, respectively. Each of these extracts was chromatographed over a silica gel column using a stepwise gradient system (hexane/ chloroform, chloroform/ethyl acetate and ethyl acetate/ methanol). Column chromatographic purification of the hexane extract gave mesuarianone (1) and mesuasinone (2). Meanwhile, the dichloromethane extract furnished 6-deoxyjacareubin (3). The same extraction procedure
(13) Fig. 1 Structures of a-mangostin, congestiflorone and congestiflorone acetate which was performed on the M. ferrea root bark (3 kg) afforded hexane (49.6 g), dichloromethane (19.5 g), ethyl acetate (16.7 g) and methanol (62.2 g) extracts. The column chromatographic separation of the hexane extract yielded four compounds which were identified as mesuaferrin A (4), mesuaferrin C (5), caloxanthone C (6) and macluraxanthone (7). Meanwhile, mesuaferrin B (8) was obtained from the dichloromethane extract. Another two xanthones 1,5-dihydroxyxanthone (9) and tovopyrifolin C (10) (Teh et al., 2013) were isolated from the ethyl acetate extract. Approximately 0.84 kg air-dried and milled sample of M. congestiflora roots was macerated sequentially with hexane, ethyl acetate and methanol at room temperature. The extracts were desiccated under reduced pressure using a rotary evaporator to yield hexane (5.5 g), ethyl acetate (61.0 g) and methanol (120.5 g) extracts. The hexane extracts afforded both a-mangostin (11) and congestiflorone (12). Structural elucidations of these compounds were achieved using 1D and 2D NMR and MS techniques.
Structural modification of compound 12
A solution of 50 mg of compound 12 in 15 mL of pyridine was added to 15 mL of acetic anhydride (Ac 2 O) and heated in a water bath at 80°C for 6 h. The reacted mixture was then dried under reduced pressure using a rotary evaporator. The crude product was then chromatographed over a silica gel column using a stepwise gradient system to obtain a yellowish oil which was elucidated to be congestiflorone acetate (13).
AChE inhibitory activity assay
AChE inhibitory activity was measured using Ellman's method with some modification. Acetylcholinesterase enzyme (AChE) was used, while acetylthiocholine iodide (ATCI) was employed as a substrate for the reaction. 5,5 0 -dithio-bis(2-nitrobenzoic) acid (DTNB) was used for the measurement of anti-AChE activity. The hydrolysis of ATCI was monitored through the formation of the yellow 5-thio-2-nitrobenzoate anion as a result of the reaction of DTNB with thiocholines, catalysed by enzymes at a wavelength of 412 nm. Every well was initially filled with 210 lL (0.15 mM/well) DTNB solution. A serial dilution was developed to obtain five different sub-stocks with different concentrations which are 100, 50, 25, 12.5, 6.25 lM. Twenty (20) lL samples was added in triplicates, and the control wells were filled with 20 lL (0.10 M, pH 7.4) of phosphate buffer, followed by 20 lL (0.037 U/mL per well) of AChE. The plate was then incubated for 10 min at 37°C. Thereafter, 20 lL (0.25 lM/well) of ATCI was added into each well to initiate the hydrolysis reaction. The plate was immediately shaken for 2 s, and the absorbance measured at 412 nm at 25°C ten times consecutively. The experiments were carried out in triplicate. Tacrine was used as a reference drug. The percentage inhibition was calculated using the following equation:
where A = average of (slope of control absorbanceslope of control colour absorbance) and B is the average of (slope of sample absorbance -slope of sample colour absorbance); colour absorbance is the absorbance of the respective sample without the addition of AChE and ATCI.
Results and discussion
Acetylcholinesterase (AChE) is the predominant cholinesterase in the brain which hydrolyses acetylcholine (ACh) to choline and acetate in order to terminate the effect of this neurotransmitter at cholinergic synapses. In other words, AChE is the target of cholinesterase inhibitors used for addressing the cholinergic deficit in Alzheimer's disease patients. Therefore, the search for anti-AChE agents from natural resources is the objective of this study. Mesua beccariana, M. ferrea and M. congestiflora were chosen for this study. The plant metabolites isolated were evaluated for their anti-AChE activities and are reported below.
Ellman's method was also used in the evaluation of antiAChE activity on the metabolites from the three species of Mesua, and the results are given in Table 1 . Among the pure metabolites, a-mangostin (11) and a synthetically derived compound from congestiflorone (12) which is congestiflorone acetate (13) gave significant inhibitory effects against the AChE enzyme with IC 50 values of 17.51 ± 0.20 and 20.25 ± 0.55 lM ( Table 1) . The other pure metabolites 1-10 and 12 were considered weak to not active due to insignificant activity with IC 50 values more than 50 lM (Fig. 2) .
Xanthones appear to be potential anti-AChE inhibitors for the reason that their main skeleton is very similar to that of tacrine (Davis and Powchik, 1995) . Xanthones are made up of three rings with a carbonyl group in the middle heterocyclic ring. There are two differences between xanthone and tacrine. Firstly, the heterocyclic ring of xanthone is an oxygen-containing ring while tacrine is a nitrogencontaining ring. Secondly, the heterocyclic ring of xanthone holds a carbonyl group while tacrine holds an amine group. However, in terms of bonding interactions, both the oxygen and nitrogen atoms in the heterocyclic ring possess hydrogen acceptor properties. Therefore, the bonding interactions of both heterocyclic rings are likely to be equivalent. However, part of the enzyme inhibition activity might be lost due to the presence of the carbonyl group in xanthone if the hydrogen donor in the amine group of tacrine is essential. This is because the amine group at the heterocyclic ring of tacrine can contribute as both a hydrogen acceptor and a donor while the carbonyl group of xanthone is only a hydrogen acceptor.
The structure-activity relationship (SAR) study on the xanthone derivatives (compounds 1-11) isolated from Mesua species revealed that a xanthone with two prenylsubstituent groups such as a-mangostin (11) will contribute to the anti-AChE effect significantly ( Fig. 1; Table 1 ). This also explains the moderate activity of the hexane extract of M. congestiflora which is contributed partly by 11. This study illustrated that xanthone derivatives with pyrano or furano rings as substituent groups (1, 2, 4-8) lose their activities. This might be due to the extra ring system which results in a bulkier skeleton which is unable to fit into the relevant region of the binding site of AChE and hence lose the binding interactions. The enzyme inhibition activity of the xanthone derivatives with a geranyl moiety such as compound 2 is reduced dramatically. This might be due to the longer alkyl chain system which cannot approach the relevant region of the binding site so closely to form the bonding interactions. Compound 9 and 10 which are simple xanthones without any pyrano or furano ring or prenyl or geranyl moieties possess no activities at all. This is due to the absence of the prenyl groups which are crucial to lock the compound into the correct position in the target binding site. The loosely fit compounds 9 and 10 fail to form any bonding interactions with the binding regions due to the improper position and are unable to approach the significant region of the binding site.
On the other hand, the result of the anti-AChE activity of congestiflorone (12) and its synthetic derivative, congestiflorone acetate (13), revealed that the presence of an acetyl group in the molecule of congestiflorone at position C-1 is mandatory. The acetyl group increases the enzyme inhibition activity of the benzophenone astonishingly. This is predicted to be highly related to the benzophenone group with the additional acetyl group at position C-1 which has close similarity to that of ACh, which is the neurotransmitter in the nervous system. The bonding interactions which can be formed by the acetyl group of ACh are exactly the same as that of compound 13. Moreover, the number of carbon atoms which join the acetyl group to the heteroatom is the same for both compounds which reflects that they have a closely similar shape. Therefore, compound 13 actually mimics the essential shape of the neurotransmitter ACh and fits well in the binding region of target and act as a potential AChE inhibitor.
Conclusions
The results of the anti-AChE activities revealed that Mesua species possess lead compounds which have high potential to be anti-AChE agents. A pure metabolite, a-mangostin and a synthetic derivative compound, congestiflorone acetate, are highly valuable as they might be potential lead compounds as anti-cholinesterase agent. Further studies on the investigation of the bioactive compounds, which are responsible for the observed biological effects, are suggested.
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